280 related articles for article (PubMed ID: 7912188)
1. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
Eldrige SR; Butterworth BE; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
[TBL] [Abstract][Full Text] [Related]
2. Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump.
Eldridge SR; Tilbury LF; Goldsworthy TL; Butterworth BE
Carcinogenesis; 1990 Dec; 11(12):2245-51. PubMed ID: 2265476
[TBL] [Abstract][Full Text] [Related]
3. Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats.
Foley J; Ton T; Maronpot R; Butterworth B; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):199-205. PubMed ID: 7912186
[TBL] [Abstract][Full Text] [Related]
4. Increased nuclear ploidy, not cell proliferation, is sustained in the peroxisome proliferator-treated rat liver.
Lalwani ND; Dethloff LA; Haskins JR; Robertson DG; de la Iglesia FA
Toxicol Pathol; 1997; 25(2):165-76. PubMed ID: 9125775
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation rates in common cancer target tissues of B6C3F1 mice and F344 rats: effects of age, gender, and choice of marker.
Eldridge SR; Goldsworthy SM
Fundam Appl Toxicol; 1996 Aug; 32(2):159-67. PubMed ID: 8921319
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2'-deoxyuridine.
Connolly KM; Bogdanffy MS
J Histochem Cytochem; 1993 Jan; 41(1):1-6. PubMed ID: 7678022
[TBL] [Abstract][Full Text] [Related]
8. Mitogenic stimulation of hepatocellular proliferation in rodents following 1,4-dichlorobenzene administration.
Eldridge SR; Goldsworthy TL; Popp JA; Butterworth BE
Carcinogenesis; 1992 Mar; 13(3):409-15. PubMed ID: 1547531
[TBL] [Abstract][Full Text] [Related]
9. NTP Hepatotoxicity Studies of the Liver Carcinogen Methapyrilene Hydrochloride (CAS No. 135-23-9) Administered in Feed to Male F344/N Rats.
Toxic Rep Ser; 2000 Feb; 46():1-C7. PubMed ID: 11986676
[TBL] [Abstract][Full Text] [Related]
10. Characterization of hepatocellular resistance and susceptibility to styrene toxicity in B6C3F1 mice.
Mahler JF; Price HC; O'Connor RW; Wilson RF; Eldridge SR; Moorman MP; Morgan DL
Toxicol Sci; 1999 Mar; 48(1):123-33. PubMed ID: 10330692
[TBL] [Abstract][Full Text] [Related]
11. Quantification of hepatocytic proliferation in the laboratory mouse. A comparative study using immunohistochemical detection of bromodeoxyuridine (BrdU) incorporation and proliferating cell nuclear antigen (PCNA) expression.
Lardelli P; Perentes E; Meier G; Navarro N; Ettlin RA
Exp Toxicol Pathol; 1994 Jul; 46(2):95-100. PubMed ID: 7987078
[TBL] [Abstract][Full Text] [Related]
12. The hepatocarcinogen methapyrilene but not the analog pyrilamine induces sustained hepatocellular replication and protein alterations in F344 rats in a 13-week feed study.
Cunningham ML; Pippin LL; Anderson NL; Wenk ML
Toxicol Appl Pharmacol; 1995 Apr; 131(2):216-23. PubMed ID: 7716764
[TBL] [Abstract][Full Text] [Related]
13. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status.
Moriki T; Takahashi T; Kataoka H; Hiroi M; Yamane T; Hara H
Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347
[TBL] [Abstract][Full Text] [Related]
14. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Lee KS; Yang WI
Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA.
Muskhelishvili L; Latendresse JR; Kodell RL; Henderson EB
J Histochem Cytochem; 2003 Dec; 51(12):1681-8. PubMed ID: 14623936
[TBL] [Abstract][Full Text] [Related]
17. Cell proliferation induced in the kidneys and livers of rats and mice by short term exposure to the carcinogen p-dichlorobenzene.
Umemura T; Tokumo K; Williams GM
Arch Toxicol; 1992; 66(7):503-7. PubMed ID: 1359854
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue.
Wijsman JH; Van Dierendonck JH; Keijzer R; van de Velde CJ; Cornelisse CJ
J Pathol; 1992 Sep; 168(1):75-83. PubMed ID: 1360499
[TBL] [Abstract][Full Text] [Related]
19. Phenobarbital-induced hepatocellular proliferation: anti-bromodeoxyuridine and anti-proliferating cell nuclear antigen immunocytochemistry.
Jones HB; Clarke NA; Barrass NC
J Histochem Cytochem; 1993 Jan; 41(1):21-7. PubMed ID: 8093255
[TBL] [Abstract][Full Text] [Related]
20. The peroxisome proliferations WY-14,643 and methylclofenapate induce hepatocyte ploidy alterations and ploidy-specific DNA synthesis in F344 rats.
Miller RT; Shah RS; Cattley RC; Popp JA
Toxicol Appl Pharmacol; 1996 Jun; 138(2):317-23. PubMed ID: 8658533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
